Browse by Projects
Jump to: 25 November 2015
Number of items: 1.
25 November 2015
Landay, A, Reither, K, Katsoulis, L, Beattie, T, Gardiner, N, Lenz, N, Said, K, Mfinanga, E, Pohl, C, Fielding, KL, Jeffery, H, Kagina, BM, Hughes, EJ, Scriba, TJ, Hanekom, WA, Hoff, ST, Bang, P, Kromann, I, Daubenberger, C, Andersen, P and Churchyard, GJ (2015). Data from: Safety and immunogenicity of H1/IC31®, an adjuvanted TB subunit vaccine, in HIV-infected adults with CD4+ Lymphocyte counts greater than 350 cells/mm3: a phase II, multi-centre, double-blind, randomized, placebo-controlled trial. [Data Collection]. Dryad. https://doi.org/10.5061/dryad.r61r8